Clinical Trials Directory

Trials / Unknown

UnknownNCT02102880

The Role of Complement Factor H Polymorphism in the Regulation of Choroidal Vascular Tone in Young Healthy Subjects

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Age related macular degeneration (AMD) is a multifactorial disease with a strong genetic component. Given that it is known that impaired regulation of choroidal vascular tone is present in patients with AMD, the current study seeks to investigate whether genetic polymorphisms in risk alleles for AMD are associated with altered choroidal blood flow regulation in healthy subjects. For this purpose a total of 220 healthy volunteers will be included. Choroidal blood flow regulation will be evaluated by measuring choroidal blood flow during isometric exercise. In addition, flicker induced vasodilatation will be studied and retinal vessel calibers will assessed, as well as retinal thickness and macular pigment optical density.

Conditions

Interventions

TypeNameDescription
GENETICthe polymerase chain reaction (PCR)

Timeline

Start date
2015-03-01
Primary completion
2023-09-02
Completion
2023-09-02
First posted
2014-04-03
Last updated
2022-04-07

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02102880. Inclusion in this directory is not an endorsement.